EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer

Dragana Petrovic

Archive of Oncology · 2002

DOI: 10.2298/aoo0202061p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archive of Oncology, 2002. Verfasst von Dragana Petrovic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Influences of CMF (cyclophosphamide, methotrexate,5-fluorouracil) chemotherapy on blood coagulation were investigated in 30 patients receiving adjuvant chemotherapy and in 30 patients receiving chemotherapy for metastatic breast cancer. METHODS: In plasma samples of 60 patients (median age 49.5), we evaluated the following parameters 1)Markers of in vivo clotting activation thrombin-antithrombin complex (ELISA) and D-dimer (ELISA), 2) Natural anticoagulants (protein C [PC] and antithrombin III [AT III] by chromogenic methods). The coagulation studies were performed at the beginning and at the end of the first cycle of CMF protocol. RESULTS: Before CMF therapy, significant difference was observed between patients with early stage and patients with metastatic breast cancer in the PC (p

Zitieren

APA

Petrovic, D. (2002). Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer. Archive of Oncology. https://doi.org/10.2298/aoo0202061p

Vancouver

Petrovic D. Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer. Archive of Oncology. 2002. doi:10.2298/aoo0202061p

BibTeX
@article{Petrovic2002,
  author = {Petrovic, Dragana},
  title = {Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer},
  journal = {Archive of Oncology},
  year = {2002},
  doi = {10.2298/aoo0202061p}
}
Kostenlos starten →